Results showed that the percentage of infection was significantly reduced in FASN siRNA treated cells as compared to siGFP or cells not treated with siRNA (Fig. 6), and that virus titer was reduced by some 4Log10 in FASN siRNA treated cells as compared to siGFP or cells not treated with siRNA (Fig. 6). The gene discussed is FASN; the disease is infection.